Skip to main content
Shanghai Kindly Enterprise Development Group Co.,Ltd. logo

Shanghai Kindly Enterprise Development Group Co.,Ltd. — Investor Relations & Filings

Ticker · 603987 ISIN · CNE100003076 LEI · 3003003G07QZESUB1P38 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 1,380 across all filing types
Latest filing 2024-06-04 Audit Report / Informat…
Country CN China
Listing Shanghai Stock Exchange 603987

About Shanghai Kindly Enterprise Development Group Co.,Ltd.

https://www.kindly-group.com/

Shanghai Kindly Enterprise Development Group Co., Ltd. specializes in the research, development, and manufacturing of medical puncture instruments and related consumables. The company's product portfolio includes a wide range of hypodermic needles, syringes, infusion sets, and blood collection devices. KDL also produces specialized medical components such as insulin needles, dental needles, and aesthetic medical instruments. With a focus on precision engineering and high-quality standards, the group serves a global market, providing essential medical supplies to healthcare facilities and distributors. The company maintains a comprehensive production chain from raw materials to finished products, ensuring consistency and safety in clinical applications.

Recent filings

Filing Released Lang Actions
德恒上海律师事务所关于上海康德莱企业发展集团股份有限公司差异化分红事项的专项核查意见
Audit Report / Information Classification · 95% confidence The document is a legal opinion issued by a law firm regarding a company's differentiated dividend distribution matter. It references specific laws, company resolutions, and dividend distribution calculations. The document is a specialized legal opinion on the dividend distribution scheme, not a financial report, earnings release, or announcement of voting results. It is not a full annual or interim report, nor a regulatory filing or announcement of a report. The document is a standalone legal audit/opinion related to a specific financial matter (dividend distribution). Therefore, it fits best under Audit Report / Information (AR), which includes standalone audit reports and applied accounting principles related to company financial matters. The document length is under 5,000 characters, but it is not merely an announcement of a report publication; it is the legal opinion itself. Hence, the classification is AR with high confidence. FY 2023
2024-06-04 Chinese
上海康德莱企业发展集团股份有限公司2023年年度权益分派实施公告
Notice of Dividend Amount Classification · 100% confidence The document is an announcement from Shanghai Kangdelai Enterprise Development Group Co., Ltd. regarding the implementation of the 2023 annual equity distribution (dividend payment). It details the dividend per share, relevant dates for record and payment, the shareholder meeting approval date, tax treatment, and instructions for dividend distribution. The document is short (2746 characters) and focuses on dividend distribution specifics rather than presenting financial statements or comprehensive financial performance. It is not a full annual report or interim report, nor is it a regulatory filing or certification. The content matches the definition of a Notice of Dividend Amount (DIV), which announces dividend amounts, payment dates, and details for shareholders.
2024-06-04 Chinese
上海康德莱企业发展集团股份有限公司提示性公告
Regulatory Filings Classification · 100% confidence The document is a short announcement (745 characters) from Shanghai Kangdelai Enterprise Development Group Co., Ltd. It informs investors about an FDA import warning related to certain medical devices, specifically plastic syringes, affecting the company's ability to export to the US market. The announcement explains the impact on sales and states the company will continue to disclose relevant information as required. There is no detailed financial data, no full report, no meeting materials, no voting results, no management changes, no earnings release, or other detailed filings. The document serves as a regulatory disclosure to inform investors of a material event affecting the company. It fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2024-05-17 Chinese
德恒上海律师事务所关于上海康德莱企业发展集团股份有限公司2023年年度股东大会之见证意见
Regulatory Filings
2024-05-13 Chinese
上海康德莱企业发展集团股份有限公司2023年年度股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a detailed announcement of the resolutions passed at the 2023 Annual General Meeting (AGM) of Shanghai Kangdelai Enterprise Development Group Co., Ltd. It includes information about the meeting date, attendance, voting results on various proposals including financial reports, profit distribution, budget, strategic plans, and appointment of auditors. The document also contains legal attestations confirming the validity and legality of the meeting and resolutions. There is no full annual report or financial statements included, but rather the official voting results and decisions made at the AGM. This matches the definition of 'Declaration of Voting Results & Voting Rights Announcements (DVA)', which covers official results from shareholder votes at any general meeting. The document length (5694 characters) and content confirm it is not merely a brief announcement or a full annual report but a detailed voting results announcement from the AGM.
2024-05-13 Chinese
关于上海康德莱企业发展集团股份有限公司向不特定对象发行可转换公司债券申请文件的审核问询函的回复报告（2023年年报更新版）
Capital/Financing Update Classification · 95% confidence The document is a detailed reply report to a review inquiry letter from the Shanghai Stock Exchange regarding the application for issuing convertible bonds by Shanghai Kangdelai Enterprise Development Group Co., Ltd. It includes extensive information about the fundraising project, including project descriptions, investment amounts, feasibility, risk disclosures, and detailed operational and technical explanations. The content focuses on the company's capital raising activities and the use of proceeds from the convertible bond issuance. The document is lengthy (15,000 characters) and contains substantive financial and operational data related to the capital raising and investment projects. This aligns with the definition of a Capital/Financing Update (CAP), which covers updates on company fundraising and financing activities. It is not an announcement of a report publication, nor a full annual or interim report, nor a regulatory filing or certification. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2024-05-07 Chinese

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.